{
    "title": "PMS reduced by 50,000 IU every two weeks - RCT",
    "slug": "pms-reduced-by-50000-iu-every-two-weeks-rct",
    "aliases": [
        "/PMS+reduced+by+50000+IU+every+two+weeks+-+RCT+Jan+2024",
        "/14974"
    ],
    "tiki_page_id": 14974,
    "date": "2024-01-15",
    "categories": [
        "Intervention",
        "Women",
        "Intervention - non daily"
    ],
    "tags": [
        "IBS",
        "Intervention",
        "Intervention - non daily",
        "NAFLD",
        "Women",
        "bipolar disorder",
        "blood levels",
        "depression",
        "diabetes",
        "diabetes and vitamin d receptor",
        "dosage",
        "genetics",
        "gut",
        "high dose",
        "liver",
        "magnesium",
        "metabolic",
        "metabolic conditions",
        "metabolic syndrome",
        "metabolic syndrome and magnesium",
        "mood disorders",
        "neurological",
        "omega 3",
        "therapeutic intervention",
        "vitamin d",
        "vitamin d blood test",
        "vitamin d receptor",
        "zinc"
    ]
}


{{< toc >}}

---

#### Effect of vitamin D supplementation on symptoms severity in vitamin D insufficient women with premenstrual syndrome: A randomized controlled trial

Clin Nutr ESPEN. 2024 Feb:59:241-248. [doi: 10.1016/j.clnesp.2023.11.014](https://doi.org/10.1016/j.clnesp.2023.11.014) PDF is behind a paywall

Hajar Heidari 1, Khadijeh Abbasi 2, Awat Feizi 3, Shahnaz Kohan 4, Reza Amani 5

Background: Premenstrual syndrome (PMS) is one of the most prevalent disorders among reproductive women worldwide that negatively impact women's quality of life. This study aimed to investigate the effect of vitamin D supplementation on the severity of PMS symptoms in vitamin D insufficient women with PMS.

Methods: In this randomized, double-blind clinical trial, 44 vitamin D insufficient women with PMS received either 50,000 IU vitamin D or a placebo fortnightly for 16 weeks. Participants completed the PMS Daily Symptoms Rating form at beginning and during the last two months of the intervention, and their blood samples were collected to assess 25(OH)D serum levels.

Results: After the four months' intervention, the serum level of 25(OH)D in the vitamin D group raised from 21 ± 8 ng/ml to 40 ± 8 ng/ml (P < 0.001), while in the placebo group it raised from 21 ± 7 ng/ml to 23 ± 7 ng/ml (P = 0.03). Indeed, serum vitamin D levels in the placebo group could not reach a sufficient level. At the end of the intervention, the mean score of total PMS symptoms showed significant improvement in the vitamin supplemented group compared to the controls (p < 0.001). By grouping the PMS symptoms into five subgroups, the mean score of all five subgroups decreased post-supplementation compared to the baseline; however, the highest and lowest decrease were in depression (53 %) and water retention subgroups (28 %), respectively. This indicates a greater improvement in the mean scores of mood symptoms compared to physical symptoms in this study (p < 0.001).

Conclusion: Results obtained in this clinical trial represent the helpful effects of vitamin D supplementation on total, physical and mood symptoms in vitamin D insufficient women with PMS.

Trial registration: This randomized controlled trial at IRCT.ir on 2018-06-20 with Registration No: IRCT20180525039822N1.

---

##### 55 References

Abdollahi R.

Abiri B.

Sarbakhsh P.

Kashanian M.

Vafa M.

 **The effect of vitamin D supplement consumption on premenstrual syndrome in vitamin D-deficient young girls: a randomized, double-blind, placebo-controlled clinical trial.** 

Complement Med Res. 2019; 26: 335-341Scopus (9)Bahrami A.

Bahrami-Taghanaki H.

Afkhamizadeh M.

Avan A.

Mazloum Khorasani Z.

Esmaeili H.

et al.

 **Menstrual disorders and premenstrual symptoms in adolescents: prevalence and relationship to serum calcium and vitamin D concentrations.

J Obstet Gynaecol. 2018; 38: 989-995** 

Abdi F.

Ozgoli G.

Rahnemaie F.S.

 **A systematic review of the role of vitamin D and calcium in premenstrual syndrome.** 

Obstetrics & gynecology science. 2019; 62: 73-86

Zaka M.

Mahmood K.T.

Pre-menstrual syndrome-a review.

J Pharmaceut Sci Res. 2012; 4: 1684

Fathizadeh S.

Amani R.

Haghighizadeh M.H.

Hormozi R.

Comparison of serum zinc concentrations and body antioxidant status between young women with premenstrual syndrome and normal controls: a case-control study.

International Journal of Reproductive BioMedicine. 2016; 14: 699

Heidari H.

Amani R.

Feizi A.

Askari G.

Kohan S.

Tavasoli P.

Vitamin D Supplementation for Premenstrual Syndrome-Related inflammation and antioxidant markers in students with vitamin D deficient: a randomized clinical trial.

Sci Rep. 2019; 9

Schiola A.

Lowin J.

Lindemann M.

Patel R.

Endicott J.

The burden of moderate/severe premenstrual syndrome and premenstrual dysphoric disorder in a cohort of Latin American women.

Value Health. 2011; 14: S93-S95

Stoner R.

Camilleri V.

Calleja-Agius J.

Schembri-Wismayer P.

The cytokine-hormone axis–the link between premenstrual syndrome and postpartum depression.

Gynecol Endocrinol. 2017; 33: 588-592

Fatemi M.

Allahdadian M.

Bahadorani M.

Comparison of serum level of some trace elements and vitamin D between patients with premenstrual syndrome and normal controls: a cross-sectional study.

International Journal of Reproductive BioMedicine. 2019; 17: 647

Sepehrirad M.

Bahrami H.

Noras M.

The role of complementary medicine in control of premenstrual syndrome evidence based (Regular Review Study).

The Iranian Journal of Obstetrics, Gynecology and Infertility. 2016; 19: 11-22Anagnostis P.

Karras S.

Goulis D.G.

Vitamin D in human reproduction: a narrative review.

Int J Clin Pract. 2013; 67: 225-235

Bahrami A.

Mazloum S.R.

Maghsoudi S.

Soleimani D.

Khayyatzadeh S.S.

Arekhi S.

et al.

High dose vitamin D supplementation is associated with a reduction in depression score among adolescent girls: a nine-week follow-up study.

J Diet Suppl. 2018; 15: 173-182

Tartagni M.

Cicinelli M.V.

Tartagni M.V.

Alrasheed H.

Matteo M.

Baldini D.

et al.

Vitamin D supplementation for premenstrual syndrome-related mood disorders in adolescents with severe hypovitaminosis D.

J Pediatr Adolesc Gynecol. 2016; 29: 357-361

Jarosz A.C.

El-Sohemy A.

Association between vitamin D status and premenstrual symptoms.

J Acad Nutr Diet. 2019; 119: 115-123

Thys-Jacobs S.

Alvir M.

Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS.

J Clin Endocrinol Metabol. 1995; 80: 2227-2232

Bertone-Johnson E.R.

Chocano-Bedoya P.O.

Zagarins S.E.

Micka A.E.

Ronnenberg A.G.

Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population.

J Steroid Biochem Mol Biol. 2010; 121: 434-437

Bertone-Johnson E.R.

Hankinson S.E.

Forger N.G.

Powers S.I.

Willett W.C.

Johnson S.R.

et al.

Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study.

BMC Wom Health. 2014; 14: 56

Saeedian Kia A.

Amani R.

Cheraghian B.

The association between the risk of premenstrual syndrome and vitamin D, calcium, and magnesium status among university students: a case control study.

Health Promot Perspect. 2015; 5: 225-230

Karimi Z.

Dehkordi M.A.

Alipour A.

Mohtashami T.

Treatment of premenstrual syndrome: appraising the effectiveness of cognitive behavioral therapy in addition to calcium supplement plus vitamin D.

PsyCh J. 2018; 7: 41-50

Khajehei M.

Abdali K.

Parsanezhad M.E.

Tabatabaee H.R.

Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome.

Int J Gynaecol Obstet. 2009; 105: 158-161Scopus (0)

Dadkhah H.

Ebrahimi E.

Fathizadeh N.

Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome: a randomized, double-blind, controlled trial.

Iran J Nurs Midwifery Res. 2016; 21: 159Sepehrmanesh Z.

Kolahdooz F.

Abedi F.

Mazroii N.

Assarian A.

Asemi Z.

et al.

Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial.

J Nutr. 2016; 146: 243-248Scopus (125)Abstract

Full Textde Medeiros Cavalcante I.G.

Silva A.S.

Costa M.J.C.

Persuhn D.C.

Issa C.I.

de Luna Freire T.L.

et al.

Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: vitamin D3 megadose reduces inflammatory markers.

Exp Gerontol. 2015; 66: 10-16Scopus (85)

Sharifi N.

Amani R.

Hajiani E.

Cheraghian B.

Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.

Endocrine. 2014; 47: 70-80Scopus (190)

Veissi M.

Anari R.

Amani R.

Shahbazian H.

Latifi S.M.

Mediterranean diet and metabolic syndrome prevalence in type 2 diabetes patients in Ahvaz, southwest of Iran.

Diabetes Metabol Syndr: Clin Res Rev. 2016; 10: S26-S29Scopus (23)Abiri B.

Vafa M.R.

Dehghani M.

Moslehi N.

Sarrafzadeh J.

Effect of vitamin D supplement consumption on muscle strength, muscle function and body composition in vitamin d-deficient middle-aged women: a randomized clinical trial.

Nutrition and Food Sciences Research. 2016; 3: 17-24

Cavalier E.

Lukas P.

Crine Y.

Peeters S.

Carlisi A.

Le Goff C.

et al.

Evaluation of automated immunoassays for 25(OH)-vitamin D determination in different critical populations before and after standardization of the assays.

Clinica chimica acta; international journal of clinical chemistry. 2014; 431: 60-65Scopus (0)

Elsenberg E.

Ten Boekel E.

Huijgen H.

Heijboer A.C.

Standardization of automated 25-hydroxyvitamin D assays: how successful is it?.

Clin Biochem. 2017; 50: 1126-1130Scopus (27)Ebrahimi E.

Motlagh S.K.

Nemati S.

Tavakoli Z.

Effects of magnesium and vitamin b6 on the severity of premenstrual syndrome symptoms.

J Caring Sci. 2012; 1: 183Abbasnezhad A.

Amani R.

Hajiani E.

Alavinejad P.

Cheraghian B.

Ghadiri A.

Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.

Neuro Gastroenterol Motil. 2016; 28: 1533-1544Scopus (50)Arab A.

Golpour-Hamedani S.

Rafie N.

The association between vitamin D and premenstrual syndrome: a systematic review and meta-analysis of current literature.

J Am Coll Nutr. 2019; 38: 648-656Scopus (19)Bahrami A.

Avan A.

Sadeghnia H.R.

Esmaeili H.

Tayefi M.

Ghasemi F.

et al.

High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents.

Gynecol Endocrinol. 2018; 34: 659-663Scopus (56)

Rafique N.

Al-Sheikh M.H.

Prevalence of menstrual problems and their association with psychological stress in young female students studying health sciences.

Saudi Med J. 2018; 39: 67

Patrick R.P.

Ames B.N.

Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior.

Faseb J. 2015; 29: 2207-2222

Tiranini L.

Nappi R.E.

Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome.

Faculty reviews. 2022; 11: 11Abdi F.

Ozgoli G.

Rahnemaie F.S.

A systematic review of the role of vitamin D and calcium in premenstrual syndrome.

Obstet Gynecol Sci. 2019; 62: 73-86

Penland J.G.

Johnson P.E.

Dietary calcium and manganese effects on menstrual cycle symptoms.

Am J Obstet Gynecol. 1993; 168: 1417-1423AbstractThys-Jacobs S.

Starkey P.

Bernstein D.

Tian J.

Premenstrual Syndrome Study Group: calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms.

Am J Obstet Gynecol. 1998; 179: 444-452

Obeidat B.A.

Alchalabi H.A.

Abdul-Razzak K.K.

Al-Farras M.I.

Premenstrual symptoms in dysmenorrheic college students: prevalence and relation to vitamin D and parathyroid hormone levels.

Int J Environ Res Publ Health. 2012; 9: 4210-4222

Bertone-Johnson E.R.

Hankinson S.E.

Bendich A.

Johnson S.R.

Willett W.C.

Manson J.E.

Calcium and vitamin D intake and risk of incident premenstrual syndrome.

Arch Intern Med. 2005; 165: 1246-1252Scopus (138)